Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anlotinib Maintenance in Extensive-Stage Small Cell Lung Cancer
NCT03781869Phase 2Unknown
- Sponsor
- Army Medical University
- Start
- Dec 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of anlotinib in small cell lung cancer (SCLC), sponsored by Army Medical University. Status: unknown.
02
Drugs
anlotinib
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT03781869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03781869.